MILD COVID-19 INFECTION PRESENTS FEW WEEKS LATER WITH DEVASTATING CARDIOVASCULAR INVOLVEMENT SEVERE LEFT VENTRICULAR IMPAIRMENT NONISCHEMIC CARDIOMYOPATHY

TYPE: Late Breaking Case Report TOPIC: Cardiovascular Disease INTRODUCTION: The (COVID 19) outbreak is a novel disease with multi-system involvement. We report a case of a young male who recovered from mild COVID 19 infection, presenting a few weeks later with devastating cardiovascular involvement severe left ventricular impairment non-ischemic cardiomyopathy dependent on a Zoll device. CASE PRESENTATION: Case of a 47 y/o male with PMH of obesity, HTN, who was apparently healthy and able to do strenuous physical activity for many years. Patient states back in March 2021, he presented with symptoms of fatigue, myalgias, and shortness of breath. He seeked medical attention and tested positive for COVID 19 by PCR. He was discharged with home quarantine and no medications given. Few weeks later no improvement at PCP. PE remarkable for acute respiratory distress, coughing, SOB on minimal exertion. Abdomen distended non-tension ascites, lower extremities 2-3 + pitting edema. O2 saturation decreased with 6 min walk to 89-90%. Patient was admitted due to anasarca, decompensated congestive heart failure. BNP elevated (2,271 pg/ml) echocardiogram EF <25% heart catheterization normal coronaries and non-ischemic cardiomyopathy were identified. NYHA stage III medical therapy was optimized Cardiac Zoll device. DISCUSSION: There is limited data about exacerbation of heart failure after mild COVID-19 infection not requiring hospitalization. This case is unique in the presentation and progression of disease with worsening of symptoms after full recovery of mild COVID-19 infection in a short period. CONCLUSIONS: It is important to continue follow up on patients due to exacerbation or complications of chronic conditions and onset of new ones as complication of this unstoppable viral infection. DISCLOSURE: Nothing to declare. KEYWORD: Non-ischemic Cardiomyopathy